208 related articles for article (PubMed ID: 12927453)
1. South African government threatens to ban nevirapine. Move would take away option for treating vertical HIV transmission.
Baleta A
Lancet; 2003 Aug; 362(9382):451. PubMed ID: 12927453
[No Abstract] [Full Text] [Related]
2. South African government procrastinates over policy on HIV drug.
Baleta A
Lancet; 2002 Feb; 359(9305):504. PubMed ID: 11853810
[No Abstract] [Full Text] [Related]
3. South African court again tells government to increase access to AIDS drug.
Baleta A
Lancet; 2002 Mar; 359(9312):1132. PubMed ID: 11943274
[No Abstract] [Full Text] [Related]
4. South Africa shifts position on antiretroviral drugs.
Baleta A
Lancet Infect Dis; 2002 Jun; 2(6):318. PubMed ID: 12144881
[No Abstract] [Full Text] [Related]
5. The right to health and the nevirapine case in South Africa.
Annas GJ
N Engl J Med; 2003 Feb; 348(8):750-4. PubMed ID: 12594322
[No Abstract] [Full Text] [Related]
6. Uganda gives lessons in stemming the AIDS epidemic.
Nat Med; 1999 Sep; 5(9):963. PubMed ID: 10470050
[No Abstract] [Full Text] [Related]
7. Nevirapine all set to succeed in Gauteng.
Bateman C
S Afr Med J; 2002 Dec; 92(12):932-3. PubMed ID: 12561400
[No Abstract] [Full Text] [Related]
8. South Africa in crisis on HIV/AIDS treatment.
Jones TT
Science; 2001 Jun; 292(5526):2431-2. PubMed ID: 11441877
[No Abstract] [Full Text] [Related]
9. Activists angry at fallout from AIDS drug trial allegations.
Check E
Nat Med; 2005 Mar; 11(3):238. PubMed ID: 15746922
[No Abstract] [Full Text] [Related]
10. South Africa's stance on nevirapine on trial.
Baleta A
Lancet; 2001 Nov; 358(9292):1521. PubMed ID: 11705576
[No Abstract] [Full Text] [Related]
11. No turning back now.
Bateman C
S Afr Med J; 2000 Sep; 90(9):837-9. PubMed ID: 11081125
[No Abstract] [Full Text] [Related]
12. Recent advances in prevention of mother to child (PMTCT) of HIV.
Musoke P
Afr Health Sci; 2004 Dec; 4(3):144-5. PubMed ID: 15687065
[No Abstract] [Full Text] [Related]
13. AZT blues.
Lala SG; Cooper PA; Gray GE; Jivkov BI; Schorn MC
S Afr Med J; 2000 Jul; 90(7):656. PubMed ID: 10985115
[No Abstract] [Full Text] [Related]
14. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Ann N Y Acad Sci; 2000 Nov; 918():53-6. PubMed ID: 11131734
[No Abstract] [Full Text] [Related]
15. S Africa state offers HIV drug to pregnant women.
Ashraf H
Lancet; 2002 Feb; 359(9304):416. PubMed ID: 11844530
[No Abstract] [Full Text] [Related]
16. Confusion over Mandela's "support" of ANC HIV policy.
Baleta A
Lancet; 2002 Mar; 359(9309):855. PubMed ID: 11897290
[No Abstract] [Full Text] [Related]
17. Establishment of drug-resistant HIV-1 in latent reservoirs.
Dahl V; Palmer S
J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
[No Abstract] [Full Text] [Related]
18. The efficacy-effectiveness gap in PMTCT.
Delva W; Temmerman M
S Afr Med J; 2004 Oct; 94(10):796. PubMed ID: 15532743
[No Abstract] [Full Text] [Related]
19. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.
Cohen J
Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490
[No Abstract] [Full Text] [Related]
20. Long-term findings of HIVNET 012: the next steps.
Beckerman KP
Lancet; 2003 Sep; 362(9387):842-3. PubMed ID: 13678965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
